Analgesic compositions containing buprenorphine
AssigneeReckitt Benckiser Healthcare (UK) Limited
InventorsChristopher Bourne Chapleo, Nicolas Calvert Varey, Keith McCormack
Life of this patent
Estimating the term…
Abstract
An analgesic composition in parenteral unit dosage form or in a unit dosage form suitable for delivery via the mucosa comprising an amount of buprenorphine which is less than the clinical dose required to achieve pain relief and an amount of naloxone such that the ratio by weight of buprenorphine to naloxone is in the range of from 12.5:1 to 27.5:1, or an amount of naltrexone or nalmefene such that the ratio by weight of buprenorphine to naltrexone or nalmefene is in the range of from 12.5:1 to 22.5:1. The analgesic action of the buprenorphine is potentiated by the low dose of naloxone, naltrexone or nalmefene.
Claims6
A method for the treatment of pain in a human or animal subject, which method comprises administering to the human or animal, by the parenteral route or via the mucosa, of from 1.25 μg to 10 μg per kilogram of body weight of buprenorphine per day and
- an amount of naloxone such that the ratio by weight of buprenorphine to naloxone administered is in the range of from 12.5:1 to 27.5:1.
Dependencies are inferred from the claim text.